{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T12:55:39Z","timestamp":1780059339394,"version":"3.54.0"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Erdheim\u2013Chester disease (ECD) is a rare non-Langerhans cell histiocytosis involving multiple systems, with central nervous system (CNS) involvement present in a significant subset. Neuropsychiatric symptoms such as cognitive decline, mood disturbances, and psychosis have been documented. However, sensitivity to psychotropic medications in CNS-involved ECD remains underreported. This case highlights a multi-mechanistically compromised CNS posing diagnostic and therapeutic challenges by such sensitivity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 50-year-old woman with biopsy-confirmed ECD and CNS involvement presented with persistent neuropsychiatric symptom confusion, psychosis, cognitive decline, mood lability, and agitation despite radiologic remission following cladribine and radiotherapy. She exhibited marked sensitivity to multiple psychotropics: haloperidol induced QTc prolongation; risperidone and aripiprazole triggered akathisia and insomnia; olanzapine caused hypotension; chlorpromazine and quetiapine led to oversedation; and benzodiazepines paradoxically worsened agitation. Only valproic acid was tolerated. Factors such as previous chemotherapy, brain radiotherapy, hypernatremia, endocrine dysfunction, and a family history of psychiatric illness were suspected to have a role in predisposition. Imaging showed lesions of the hypothalamus, pituitary stalk, and mesial temporal lobes. Persistent symptoms shared features with Lewy Body Dementia and raised the diagnostic ambiguity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>To our knowledge, this is one of the first detailed reports to describe heightened neuropsychiatric instability and psychotropic intolerance in a patient with a compromised CNS through several suspected mechanisms. The case underscores the need for multidisciplinary care and cautious psychiatric management in patients with a compromised CNS. Clinicians should suspect psychotropic sensitivity in cases with paradoxical responses and consider systemic causes such as ECD as a possible contributor.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyt.2026.1752665","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T05:48:02Z","timestamp":1776059282000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: Neuropsychiatric instability in structurally compromised CNS Erdheim\u2013Chester disease: a diagnostic and management challenge"],"prefix":"10.3389","volume":"17","author":[{"given":"Abdulaziz F.","family":"Alfraiji","sequence":"first","affiliation":[{"name":"Department of Psychiatry, College of Medicine, King Saud University","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed F.","family":"Alqahtani","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, College of Medicine, King Saud University","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahad","family":"Aljudi","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, College of Medicine, King Saud University","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad D.","family":"Alosaimi","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, College of Medicine, King Saud University","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-8-137","article-title":"Erdheim-Chester Disease: a comprehensive review of the literature","volume":"8","author":"Mazor","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122692","article-title":"Advances in understanding and management of erdheim-chester disease","volume":"348","author":"Kulkarni","year":"2024","journal-title":"Life Sci"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-04-570937","article-title":"Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease","volume":"124","author":"Emile","year":"2014","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000010748","article-title":"Central nervous system involvement in Erdheim-Chester disease: An observational cohort study","volume":"95","author":"Cohen Aubart","year":"2020","journal-title":"Neurology"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018030502","article-title":"A scale for patient-reported symptom assessment for patients with Erdheim-Chester disease","volume":"3","author":"Diamond","year":"2019","journal-title":"Blood Adv"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-022-02609-x","article-title":"Psychiatric disorders, personality and neuropsychological alterations in Erdheim-Chester disease","volume":"18","author":"Soumet-Leman","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noaa008","article-title":"Neurologic and oncologic features of Erdheim-Chester disease: a 30-patient series","volume":"22","author":"Bhatia","year":"2020","journal-title":"Neuro Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2016001784","article-title":"The clinical spectrum of Erdheim-Chester disease: an observational cohort study","volume":"1","author":"Estrada-Veras","year":"2017","journal-title":"Blood Adv"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.918613","article-title":"Dramatic efficacy of interferon and vemurafenib on psychiatric symptoms revealing BRAFV600E-mutated Erdheim-Chester disease: a case report","volume":"13","author":"Razanamahery","year":"2022","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2011.03.014","article-title":"An update on cancer- and chemotherapy-related cognitive dysfunction: current status","volume":"38","author":"Janelsins","year":"2011","journal-title":"Semin Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms161126068","article-title":"Molecular, cellular and functional effects of radiation-induced brain injury: a review","volume":"16","author":"Balentova","year":"2015","journal-title":"Int J Mol Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12968\/hmed.2024.0822","article-title":"Comprehensive overview of hypernatremia: pathophysiology, diagnosis, and management","volume":"86","author":"Mittal","year":"2025","journal-title":"Br J Hosp Med (Lond)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1358873","article-title":"Mast cell activation triggered by SARS-CoV-2 causes inflammation in brain microvascular endothelial cells and microglia","volume":"14","author":"Wu","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1592\/phco.24.13.1177.38089","article-title":"Paradoxical reactions to benzodiazepines: literature review and treatment options","volume":"24","author":"Mancuso","year":"2004","journal-title":"Pharmacotherapy"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s41999-025-01348-z","article-title":"The etiology of delirium in long-term care settings: a Lernaean Hydra","author":"Rouabhia","year":"2025","journal-title":"Eur Geriatr Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200216100-00003","article-title":"Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy","volume":"16","author":"L\u00f6scher","year":"2002","journal-title":"CNS Drugs"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1177\/08850666241302760","article-title":"Valproic acid for hyperactive delirium and agitation in critically ill patients","volume":"40","author":"Nuti","year":"2025","journal-title":"J Intensive Care Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci13030414","article-title":"Application of antipsychotic drugs in mood disorders","volume":"13","author":"Rybakowski","year":"2023","journal-title":"Brain Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-006-0160-9","article-title":"Neurological manifestations and neuroradiological presentation of Erdheim-Chester disease: report of 6 cases and systematic review of the literature","volume":"253","author":"Lachenal","year":"2006","journal-title":"J Neurol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-20-1447","article-title":"Serum sodium alterations in SARS-CoV-2 (COVID-19) infection: impact on patient outcome","volume":"185","author":"Berni","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.305.6855.673","article-title":"Neuroleptic sensitivity in patients with senile dementia of Lewy body type","volume":"305","author":"McKeith","year":"1992","journal-title":"BMJ"},{"key":"B22","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s40263-014-0196-9","article-title":"QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive review","volume":"28","author":"Hasnain","year":"2014","journal-title":"CNS Drugs"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1177\/08850666231222470","article-title":"Risk stratification of QTc prolongation in critically ill patients receiving antipsychotics for the management of delirium symptoms","volume":"40","author":"Sadlonova","year":"2025","journal-title":"J Intensive Care Med"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1752665\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T05:48:03Z","timestamp":1776059283000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1752665\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":23,"alternative-id":["10.3389\/fpsyt.2026.1752665"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2026.1752665","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"article-number":"1752665"}}